Comparison of osimertinib plus bevacizumab against osimertinib alone in NSCLC harboring EGFR mutations: a systematic review and meta-analysis
Zhou, Guojin, Guo, Liuxian, Xu, Jing, Tang, Kejing, Chen, Jie
Published in Therapeutic advances in medical oncology (01.01.2024)
Published in Therapeutic advances in medical oncology (01.01.2024)
Get full text
Journal Article
The impact of EGFR T790M mutation status following the development of Osimertinib resistance on the efficacy of Osimertinib in non‐small cell lung cancer: A meta‐analysis
Guo, Liuxian, Zhou, Guojin, Huang, Min, Tang, Kejing, Xu, Jing, Chen, Jie
Published in The clinical respiratory journal (01.04.2024)
Published in The clinical respiratory journal (01.04.2024)
Get full text
Journal Article
Nephrotoxicity induced by cisplatin is primarily due to the activation of the 5-hydroxytryptamine degradation system in proximal renal tubules
Guan, Jing, Tong, Xin, Zhang, Yi, Xu, Fan, Zhang, Yuxin, Liang, Xiurui, Jin, Jiaqi, Jing, Hongyan, Guo, Liuxian, Ni, Xinrui, Fu, Jihua
Published in Chemico-biological interactions (01.11.2021)
Published in Chemico-biological interactions (01.11.2021)
Get full text
Journal Article